Progression of head and neck squamous cell cancer

被引:0
|
作者
József Tímár
Orsolya Csuka
Éva Remenár
Gábor Répássy
Miklós Kásler
机构
[1] National Institute of Oncology,Department of Oto
[2] Semmelweis University,Rhyno
来源
关键词
head and neck cancer; invasion marker; lymphatic metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
Squamous cell cancer in the head and neck region (HNSC) is unique concerning its progression since it remains locoregional for long time and visceral metastases develop only in a later stage of the disease. Accordingly, molecular markers of the local invasion and the lymphatic dissemination both have critical importance. HNSC progression is associated with deregulated control of cell proliferation and apoptosis but it seems equally significant the disregulation of the proteolytic machineries. Here we outline the lymphatic metastatic cascade for HNSC to depict key molecular determinants as possible prognostic factors or therapeutic targets identifying immunological selection as a major feature. Unlike in local spreading, invasive potential of cancer cells seems to be less significant during lymphatic dissemination due to the anatomical properties of the lymphatic vessels and tissues. There is a general believe that HNSC is one disease however, data indicate that the anatomical localization of the tumor (the “soil”) such as oral, lingual, glottic or pharyngeal has a significant effect on the gene expression profile and corresponding biological behavior of HNSC. Furthermore, even the endocrine milieu of the host was proved to be influential in modulating the progression of HNSC. Gene expression profiling techniques combined with proteomics could help to define and select usefull genetic and biomarkers of progression of HNSC, some of them could well be potential novel therapeutic target.
引用
收藏
页码:107 / 127
页数:20
相关论文
共 50 条
  • [21] Systemic chemotherapy for squamous cell head and neck cancer
    Adelstein, DJ
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (12) : 2151 - 2163
  • [22] Karyotypic evolution and tumor progression in head and neck squamous cell carcinomas
    Jin, YS
    Jin, C
    Lv, M
    Tsao, SW
    Zhu, JK
    Wennerberg, J
    Mertens, F
    Kwong, YL
    CANCER GENETICS AND CYTOGENETICS, 2005, 156 (01) : 1 - 7
  • [23] Galectins as modulators of tumor progression in head and neck squamous cell carcinomas
    Saussez, Sven
    Camby, Isabelle
    Toubeau, Gerard
    Kiss, Robert
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (09): : 874 - 884
  • [24] New Candidate Markers of Head and Neck Squamous Cell Carcinoma Progression
    Kakurina, G. V.
    Kolegova, E. S.
    Cheremisina, O. V.
    Kulbakin, D. E.
    Choinzonov, E. L.
    PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS (PC IPCA), 2017, 1882
  • [25] Epigenetic events of disease progression in head and neck squamous cell carcinoma
    Worsham, Maria J.
    Chen, Kang Mei
    Meduri, Venkata
    Nygren, Anders O. H.
    Errami, Abdellatif
    Schouten, Jan P.
    Benninger, Michael S.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2006, 132 (06) : 668 - 677
  • [26] The Cancer Stem Cell Concept in Progression of Head and Neck Cancer
    Chen, Zhuo
    JOURNAL OF ONCOLOGY, 2009, 2009
  • [27] Understanding genetic progression of squamous cell carcinoma to spindle cell carcinoma in a mouse model of head and neck cancer
    Chuang, Rita
    Crowe, David L.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 30 (05) : 1279 - 1287
  • [28] Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma
    Major, Aidan G.
    Pitty, Luke P.
    Farah, Camile S.
    STEM CELLS INTERNATIONAL, 2013, 2013
  • [29] The role of cetuximab in the treatment of squamous cell cancer of the head and neck
    Burtness, B
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (08) : 1085 - 1093
  • [30] THE ROLE OF CHEMOTHERAPY IN SQUAMOUS-CELL CANCER OF THE HEAD AND NECK
    SCHRODER, M
    VONHEYDEN, HW
    HNO, 1981, 29 (07) : 225 - 239